RECRUITING
I'm interested ...!!
HIV Treatment Adherence Dose Determination Trial
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Conditions:
🦠 HIV Infections
🗓️ Study Start (Actual) 1 September 2020
🗓️ Primary Completion (Estimated) 30 November 2023
✅ Study Completion (Estimated) 30 November 2024
👥 Enrollment (Estimated) 400
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Storrs, Connecticut, United States
📍 Atlanta, Georgia, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Confirmed HIV positive
    • * Confirmed prescribed antiretroviral therapy
    • * Confirmed non-adherent to anti-retroviral therapy

    Exclusion Criteria:

    • * Does not have access to a phone
    • * Does not have access to the internet
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 23 September 2020
  • First Submitted that Met QC Criteria 29 September 2020
  • First Posted 6 October 2020

Study Record Updates

  • Last Update Submitted that Met QC Criteria 13 October 2021
  • Last Update Posted 15 October 2021
  • Last Verified October 2021
I'm interested ...!!